A Study of RC18 Administered Subcutaneously to Subjects With Primary IgA(Immunoglobulin A) Nephropathy
Clinical trial NCT04291781 · COMPLETED
Trial details
- NCT number
- NCT04291781
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-13
- Primary completion
- 2021-05-20
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.